Pathogenic autoantibodies in systemic sclerosis (SSc). | Download Table
Patients with multiple scleroderma-specific antinuclear antibodies | Download Table
Scleroderma – Symptoms and Causes | Penn Medicine
Seroconversion from Anti-Th/To to Anticentromere Antibodies in a Patient with Systemic Sclerosis | The Journal of Rheumatology
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets - ScienceDirect
JCM | Free Full-Text | Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Scleroderma | NEJM
Autoantibodies and Their Role in Scleroderma Clinical Care | Current Treatment Options in Rheumatology
Tests for Autoimmune Diseases | Quest Diagnostics
Auto-antibody testing — gpraj
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma? - ScienceDirect
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology
Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies | Semantic Scholar
Scl-70 | Lab Tests Guide
Renal involvement in systemic sclerosis - ScienceDirect
Scleroderma Antibodies and Clinical Relevance – Scleroderma Education Project
The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis
Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis | NEJM
Scleroderma - getting diagnosed | SRUK
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis - ScienceDirect
Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification
Connective Tissue Diseases
Frontiers | Precursors to Systemic Sclerosis and Systemic Lupus Erythematosus: From Undifferentiated Connective Tissue Disease to the Development of Identifiable Connective Tissue Diseases
Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification